rotenone and agmatine
rotenone has been researched along with agmatine in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Caccamo, D; Condello, S; Currò, M; Ferlazzo, N; Ientile, R; Satriano, J | 1 |
| Caccamo, D; Calabrò, E; Condello, S; Currò, M; Ferlazzo, N; Ientile, R; Magazù, S; Satriano, J | 1 |
| Ahmed, A; El-Sayed, EK; Morsy, EE; Nofal, S | 1 |
| Caccamo, D; Currò, M; Ferlazzo, N; Giunta, ML; Ientile, R; Longo, D; Rizzo, V | 1 |
| Avci, B; Bilge, SS; Bozkurt, A; Günaydin, C; Önger, ME | 1 |
| Azar, YO; Badawi, GA; Ibrahim, SM; Zaki, HF | 1 |
Other Studies
6 other study(ies) available for rotenone and agmatine
| Article | Year |
|---|---|
Agmatine effects on mitochondrial membrane potential and NF-κB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells.
Topics: Agmatine; Apoptosis; Cell Death; Cell Line, Tumor; Humans; Membrane Potential, Mitochondrial; Neurons; Neuroprotective Agents; NF-kappa B; Rotenone | 2011 |
Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: fourier transform infrared spectroscopy analysis in a model of Parkinson's disease.
Topics: Agmatine; Cell Line, Tumor; Humans; Models, Biological; Neuroblastoma; Parkinson Disease; Rotenone; Spectroscopy, Fourier Transform Infrared | 2012 |
Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
Topics: Agmatine; Animals; Cytokines; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glutathione; Male; Malondialdehyde; Mesencephalon; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Rats, Sprague-Dawley; Rotenone; Tyrosine 3-Monooxygenase | 2019 |
Up-regulation of HIF-1α is associated with neuroprotective effects of agmatine against rotenone-induced toxicity in differentiated SH-SY5Y cells.
Topics: Agmatine; Apoptosis; Cell Differentiation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insecticides; Neurons; Neuroprotective Agents; Rotenone; Up-Regulation | 2020 |
Neuroprotective action of agmatine in rotenone-induced model of Parkinson's disease: Role of BDNF/cREB and ERK pathway.
Topics: Agmatine; Animals; Apoptosis; Brain; Brain-Derived Neurotrophic Factor; Cell Survival; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Male; MAP Kinase Signaling System; Neuronal Plasticity; Neurons; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Signal Transduction | 2020 |
Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats.
Topics: Agmatine; Animals; Antioxidants; Dyskinesias; HMGB1 Protein; Levodopa; Myeloid Differentiation Factor 88; NF-E2-Related Factor 2; NF-kappa B; Oxidopamine; Parkinson Disease; Rats; Receptors, N-Methyl-D-Aspartate; Rotenone; Signal Transduction; Toll-Like Receptor 4 | 2022 |